Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma

[1]  Michael Biehl,et al.  Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study , 2020, The lancet. Diabetes & endocrinology.

[2]  J. Greenfield,et al.  Urinary steroid profiling in diagnostic evaluation of an unusual adrenal mass , 2019, Endocrinology, diabetes & metabolism case reports.

[3]  Martin Fassnacht,et al.  Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma. , 2019, European journal of endocrinology.

[4]  V. Chortis,et al.  The role of steroid metabolome analysis for the diagnosis and follow-up of adrenocortical tumors. , 2018, Minerva endocrinologica.

[5]  O. Dekkers,et al.  Influence of hormonal functional status on survival in adrenocortical carcinoma: systematic review and meta-analysis. , 2018, European journal of endocrinology.

[6]  Eric Baudin,et al.  European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors. , 2018, European journal of endocrinology.

[7]  W. Young,et al.  High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal Disorders. , 2017, Clinical chemistry.

[8]  Dylan Lewis,et al.  A 13-Steroid Serum Panel Based on LC-MS/MS: Use in Detection of Adrenocortical Carcinoma. , 2017, Clinical chemistry.

[9]  W. Arlt,et al.  Diagnosis of a malignant adrenal mass: the role of urinary steroid metabolite profiling , 2017, Current opinion in endocrinology, diabetes, and obesity.

[10]  Fares Alahdab,et al.  DIAGNOSIS OF ENDOCRINE DISEASE: The diagnostic performance of adrenal biopsy: a systematic review and meta-analysis. , 2016, European journal of endocrinology.

[11]  E. Bessonova,et al.  Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma , 2016, Hormones and Cancer.

[12]  F. Labrie,et al.  Letter to the Editor: Superior Mass Spectrometry-Based Estrogen Assays Should Replace Immunoassays. , 2015, The Journal of clinical endocrinology and metabolism.

[13]  R. Santen,et al.  Response to the Letter by Labrie et al. , 2015, Journal of Clinical Endocrinology and Metabolism.

[14]  H. Sasano,et al.  Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis. , 2015, Endocrinology and metabolism clinics of North America.

[15]  I. Kema,et al.  Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors , 2015, Hormones and Cancer.

[16]  R. Ziegler,et al.  Measuring Estrogen Exposure and Metabolism: Workshop Recommendations on Clinical Issues. , 2015, The Journal of clinical endocrinology and metabolism.

[17]  David Handelsman,et al.  Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. , 2013, The Journal of clinical endocrinology and metabolism.

[18]  C. Schade-Brittinger,et al.  Combination chemotherapy in advanced adrenocortical carcinoma. , 2012, The New England journal of medicine.

[19]  Michael Biehl,et al.  Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors , 2011, The Journal of clinical endocrinology and metabolism.

[20]  J. Bertherat,et al.  Transcriptome analysis of adrenocortical cancers: from molecular classification to the identification of new treatments. , 2011, Endocrine-related cancer.

[21]  F. Montorsi,et al.  The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation. , 2010, European journal of cancer.

[22]  J. Bertherat,et al.  Adrenocortical cancer: pathophysiology and clinical management. , 2007, Endocrine-related cancer.

[23]  J. Bertherat,et al.  Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. , 2006, The Journal of clinical endocrinology and metabolism.

[24]  Martin Fassnacht,et al.  Adrenocortical Carcinoma: Clinical Update , 2006 .

[25]  J. Bertherat,et al.  Cushing ’ s syndrome , 2003 .

[26]  L. Nieman,et al.  Cushing's syndrome , 2005 .

[27]  A B Atkinson,et al.  Diagnosis and complications of Cushing's syndrome: a consensus statement. , 2003, The Journal of clinical endocrinology and metabolism.

[28]  Y. Chapuis,et al.  Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group , 2001, World Journal of Surgery.

[29]  A. Halpern,et al.  Clinical, hormonal and pathological findings in a comparative study of adrenocortical neoplasms in childhood and adulthood. , 1995, The Journal of urology.

[30]  L. Medeiros,et al.  Pathologic Features of Prognostic Significance in Adrenocortical Carcinoma , 1989, The American journal of surgical pathology.

[31]  S DeCandia,et al.  [Cushing's syndrome]. , 1951, Il Policlinico. Sezione pratica.

[32]  Michael Biehl,et al.  University of Groningen Urine steroid metabolomics as a novel tool for detection of recurrent adrenocortical carcinoma , 2020 .

[33]  Else,et al.  Guidelines on the management of adrenocortical carcinoma in adults , in collaboration with the European Network for the Study of Adrenal Tumors , 2018 .

[34]  W. Clarke,et al.  High resolution accurate mass (HRAM) mass spectrometry , 2017 .

[35]  T. Fahey,et al.  Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors , 2012 .

[36]  Takashi Suzuki,et al.  Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma , 2006, Endocrine pathology.

[37]  Linda Ng,et al.  Adrenocortical carcinoma: diagnosis, evaluation and treatment. , 2003, The Journal of urology.

[38]  P. Devos,et al.  A Clinicopathologic and Immunohistochemical Study of 49 Adrenocortical Tumors , 2002 .

[39]  Lippincott Williams Wilkins,et al.  The American journal of surgical pathology , 1977 .